Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study on robot-assisted retinal vein cannulation with ocriplasmin (Jetrea) infusion for central retinal vein occlusion
2015-005473-20Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Dec 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ocriplasmin in central retinal vein occlusion (CRVO), sponsored by UZ Leuven. Primary endpoint: Change in visual acuity. Started Dec 2015; status: completed.
02
Drugs
ocriplasmin
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2015-005473-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005473-20.